David Risinger

Work

Analyst David Risinger works at LEERINK and is focused on the Healthcare sector with 629 price targets and ratings documented since 2012 spanning on 28 stocks. Previously, David Risinger worked at MORGAN STANLEY. Analyst's average stock valuation to be materialised ratio is 72.76% with an average time for price targets to be met of 218.93 days.

Most recent stock forecast was given on GILD, Gilead Sciences, Inc at 03-Feb-2023.

David Risinger best performing recommendations are on BHC (BAUSCH HEALTH COMPANIES INC).
The best stock recommendation documented was for ALKS (ALKERMES PLC) at 1/21/2016. The price target of $35 was fulfilled within 1 day with a profit of $1.31 (3.89%) receiving and performance score of 38.88.

Average potential price target upside

ABBV AGN ALKS BHC ELAN ENDP GILD HZNP JAZZ LLY MNK MYL PRGO TEVA ZTS BMY JNJ PFE PAHC ROIV VTRS HALO MRK RDUS REGN TBPH AMGN VRTX

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

157

$12.16 (8.40%)

155

18 days ago

33/34 (97.06%)

$24.49 (29.07%)

425

Buy

182

$37.16 (25.66%)

178

1 months 29 days ago

14/22 (63.64%)

$25.08 (28.76%)

561

Hold

140

$-4.84 (-3.34%)

172

2 months 27 days ago

0/2 (0%)

$25.87 (23.60%)

Hold

155

$10.16 (7.01%)

160

3 months 4 days ago

7/8 (87.5%)

$12.27 (10.71%)

76

Buy

169

$24.16 (16.68%)

174

3 months 4 days ago

11/13 (84.62%)

$16.17 (14.62%)

118

Show more analysts
ABBV AGN ALKS BHC ELAN ENDP GILD HZNP JAZZ LLY MNK MYL PRGO TEVA ZTS BMY JNJ PFE PAHC ROIV VTRS HALO MRK RDUS REGN TBPH AMGN VRTX